• Lead global HEOR/RWE strategy and evidence generation activities for the BTK degrader asset across product lifecycle, ensuring alignment with cross-functional objectives • Develop and execute integrated value evidence generation plan, including disease burden, treatment patterns, comparative effectiveness, indirect comparisons, economic modeling, and patient-centered outcomes to demonstrate clinical and economic value • Design and execute real-world evidence and comparative effectiveness studies using various real-world data sources including claims and electronic health records to support differentiation • Collaborate with cross-functional partners on JCA/HTA submissions and lead key HEOR deliverables timely including indirect comparisons and economic modeling • Lead development of Global Value Dossiers and US AMCP dossier to support reimbursement submissions and value communication • Drive scientific dissemination of HEOR/RWE evidence through abstracts, manuscripts, and congress presentations and omnichannel distributions